Alzheimer’s Disease Therapeutics: Alternatives to Amyloid
Event Date: December 11, 2018
Deadline to Submit Abstracts: November 2, 2018
For years, the Alzheimer’s research community has been focused on amyloid as the key to curing this devastating disease. However, there are currently only four drugs approved to treat the symptoms of Alzheimer’s disease, and no new therapies have been approved in the last 15 years. Moreover, multiple clinical trials have recently failed, including several Phase III trials that targeted amyloid with antibodies. As a result, there is burgeoning interest in identifying alternative drug targets: over half of ongoing preclinical research in Alzheimer’s disease now focuses on pathways other than amyloid and tau.
This one-day symposium will highlight emerging mechanisms driving Alzheimer's disease — including mitochondrial factors, the vascular system, infections, and autophagy — as well as discuss strategies to identify new therapeutic targets.
To register for this event, please visit the main website at: www.nyas.org/AmyloidAlternatives